Cargando…
Predicted Secondary Malignancies following Proton versus Photon Radiation for Oropharyngeal Cancers
PURPOSE: There has been a recent epidemic of human papillomavirus (HPV)–positive oropharyngeal cancer, accounting for 70% to 80% of diagnosed cases. These patients have an overall favorable prognosis and are typically treated with a combination of surgery, chemotherapy, and radiation. Because these...
Autores principales: | Jain, Varsha, Irmen, Peyton, O'Reilly, Shannon, Vogel, Jennifer H., Lin, Liyong, Lin, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Particle Therapy Co-operative Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302732/ https://www.ncbi.nlm.nih.gov/pubmed/32582814 http://dx.doi.org/10.14338/IJPT-19-00076.1 |
Ejemplares similares
-
Secondary Malignancy Risk Following Proton Radiation Therapy
por: Eaton, Bree R., et al.
Publicado: (2015) -
Higher Dose Volumes May Be Better for Evaluating Radiation Pneumonitis in Lung Proton Therapy Patients Compared With Traditional Photon-Based Dose Constraints
por: Harris, Wendy B., et al.
Publicado: (2020) -
Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer
por: Thaker, Nikhil G., et al.
Publicado: (2021) -
Proton versus photon radiation therapy: A clinical review
por: Chen, Zhe, et al.
Publicado: (2023) -
Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer
por: Smith, Grace L., et al.
Publicado: (2021)